MedPath

Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study

Completed
Conditions
Soft Tissue Sarcoma
Registration Number
NCT00611078
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:
  • Between 18 and 79 years of age
  • were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma
  • are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)
  • controls will be eligibile for this study if they meet the following criteria
  • are b/w 18-79 years of age
  • have no prior history of cancer (other than non melanoma skin cancer)
Read More
Exclusion Criteria
  • Individuals will be excluded if they
  • are unable to sign informed consent for medical or other reasons
  • do not speak english
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
enrollment of 60 participantsConclusion of the study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath